Reversing insulin resistance, guided by biomarkers.

Part 1. What insulin resistance actually is.

Insulin's job is to move glucose from your bloodstream into your cells so those cells can use it as fuel or store it for later. When cells stop responding to insulin the way they should, glucose stays in circulation for longer than it is meant to, and the pancreas responds by producing more insulin to try to push the glucose in. That elevated, persistent insulin level is the biochemistry behind what wellness culture flattens into "carb intolerance" or "hormonal imbalance."

The knock-on effects are the reason insulin resistance is a load-bearing condition for so much else. Chronically raised insulin drives fat storage, particularly around the liver and midsection. It suppresses fat-burning. It disrupts ovarian function, which is where the PCOS crossover starts. It contributes to inflammation, which shows up in skin, joints and mood. And left long enough, it moves someone from insulin resistant to insulin resistant with elevated blood glucose, which is the definition of type 2 diabetes.

None of this is a moral failing or a willpower problem, and framing it that way is one of the most damaging things a practitioner can do. It is a biochemistry problem with biochemical drivers, and it responds to biochemical intervention.

Part 2. The biomarker panel that tells you where you are.

The single most common mistake in this space is treating fasting glucose as if it tells you the whole story. It does not. Fasting glucose is a lagging indicator, and someone can be significantly insulin resistant for years before their fasting glucose leaves the "normal" range on a standard blood panel. The panel that actually reveals where you stand is more nuanced.

HbA1c. A three-month average of your blood glucose. A number in the 5.7 to 6.4 range signals prediabetes; anything above 6.5 signals type 2 diabetes. Both numbers move in response to protocol changes, which is why HbA1c gets measured at baseline, at each review point, and again at discharge.

Fasting insulin. The elevated-insulin story does not show up on glucose alone; you have to actually measure insulin. Anything above 10 mIU/L flags insulin resistance well before glucose starts drifting.

HOMA-IR. A calculated ratio combining fasting glucose and fasting insulin. Above 1.9 typically signals early insulin resistance; above 2.9 signals significant resistance.

Triglyceride-to-HDL ratio. A cheap and revealing metabolic-health marker. A ratio above 2 in mmol/L (or above 3.5 in mg/dL) correlates strongly with insulin resistance even when other markers look acceptable.

Part 3. The mechanism of reversal, and what a client typically sees.

Reversing insulin resistance is not about eliminating any single food, taking any single supplement, or following any single diet. It is about restoring the sensitivity of your cells to insulin's signal, which happens through several parallel levers.

The first lever is the composition of what you eat. Refined carbohydrates and industrial seed oils are the two dietary categories that most reliably drive insulin resistance, and reducing both is where most protocols begin. The second lever is the timing of what you eat. Extended overnight fasts, no snacking between meals, and finishing the day's eating earlier all improve insulin sensitivity independent of what you eat. The third lever is movement, particularly resistance training, which acts as an insulin-sensitising drug without needing to be prescribed as one. The fourth lever is sleep, which the sleep piece in this archive covers in more depth. The fifth lever, in Maria's practice, is where Ayurvedic constitutional work adjusts the details of the above to match how your particular body responds.

The typical trajectory a client sees is measurable within twelve weeks. Fasting insulin usually drops first, often meaningfully. HOMA-IR follows. HbA1c takes longer to shift because it is an averaged number, but a first review at week 12 will usually show it moving. Discharge, when it comes, is at the point where the numbers hold in the healthy range for three months without protocol intervention.